229 related articles for article (PubMed ID: 20553281)
1. Local drug delivery for treatment of coronary and peripheral artery disease.
Gertz ZM; Wilensky RL
Cardiovasc Ther; 2011 Dec; 29(6):e54-66. PubMed ID: 20553281
[TBL] [Abstract][Full Text] [Related]
2. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
3. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
[TBL] [Abstract][Full Text] [Related]
4. In-stent restenosis: the gold standard has changed.
Chin K
EuroIntervention; 2011 May; 7 Suppl K():K43-6. PubMed ID: 22027726
[TBL] [Abstract][Full Text] [Related]
5. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
Waksman R; Pakala R
EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
[TBL] [Abstract][Full Text] [Related]
6. PCI in small vessels: the case for a drug-coated balloon based intervention.
Zeymer U; Scheller B
EuroIntervention; 2011 May; 7 Suppl K():K57-60. PubMed ID: 22027729
[No Abstract] [Full Text] [Related]
7. Lesions in small coronary vessels disease: should drug-coated balloons replace drug-eluting stents as the treatment of choice?
Byrne RA; Kastrati A
EuroIntervention; 2011 May; 7 Suppl K():K47-52. PubMed ID: 22027727
[TBL] [Abstract][Full Text] [Related]
8. Local drug delivery - the early Berlin experience: single drug administration versus sustained release.
Speck U; Scheller B; Rutsch W; Laule M; Stangl V
EuroIntervention; 2011 May; 7 Suppl K():K17-22. PubMed ID: 22027723
[TBL] [Abstract][Full Text] [Related]
9. Targeted vascular drug delivery. A new day for an old way.
Buchbinder M; Solar R
Panminerva Med; 2013 Dec; 55(4):353-61. PubMed ID: 24434344
[TBL] [Abstract][Full Text] [Related]
10. Everolimus-eluting bioabsorbable stent--Abbot Vascular programme.
Onuma Y; Piazza N; Ormiston JA; Serruys PW
EuroIntervention; 2009 Dec; 5 Suppl F():F98-F102. PubMed ID: 22100687
[No Abstract] [Full Text] [Related]
11. Antiplatelet therapy in the era of percutaneous coronary intervention with drug-eluting balloons.
Bonaventura K; Sonntag S; Kleber FX
EuroIntervention; 2011 May; 7 Suppl K():K106-11. PubMed ID: 22027718
[TBL] [Abstract][Full Text] [Related]
12. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
13. Drug-eluting stents and drug-coated balloons in peripheral artery disease.
Buechel R; Stirnimann A; Zimmer R; Keo H; Groechenig E
Vasa; 2012 Jul; 41(4):248-61. PubMed ID: 22825858
[TBL] [Abstract][Full Text] [Related]
14. How to use the drug-eluting balloon: recommendations by the German consensus group.
Kleber FX; Mathey DG; Rittger H; Scheller B;
EuroIntervention; 2011 May; 7 Suppl K():K125-8. PubMed ID: 22027722
[No Abstract] [Full Text] [Related]
15. Assimilating the current clinical data of fully bioabsorbable stents.
Di Mario C; Borgia F
EuroIntervention; 2009 Dec; 5 Suppl F():F103-8. PubMed ID: 22100669
[No Abstract] [Full Text] [Related]
16. Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries.
Nakano K; Egashira K; Masuda S; Funakoshi K; Zhao G; Kimura S; Matoba T; Sueishi K; Endo Y; Kawashima Y; Hara K; Tsujimoto H; Tominaga R; Sunagawa K
JACC Cardiovasc Interv; 2009 Apr; 2(4):277-83. PubMed ID: 19463437
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells.
Clever YP; Cremers B; Krauss B; Böhm M; Speck U; Laufs U; Scheller B
EuroIntervention; 2011 May; 7 Suppl K():K32-42. PubMed ID: 22027725
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel-eluting balloon: from bench to bed.
De Labriolle A; Pakala R; Bonello L; Lemesle G; Scheinowitz M; Waksman R
Catheter Cardiovasc Interv; 2009 Apr; 73(5):643-52. PubMed ID: 19309715
[TBL] [Abstract][Full Text] [Related]
19. OrbusNeich fully absorbable coronary stent platform incorporating dual partitioned coatings.
Cottone RJ; Thatcher GL; Parker SP; Hanks L; Kujawa DA; Rowland SM; Costa M; Schwartz RS; Onuma Y
EuroIntervention; 2009 Dec; 5 Suppl F():F65-71. PubMed ID: 22100679
[TBL] [Abstract][Full Text] [Related]
20. Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study.
Beijk MA; Klomp M; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; Tijssen JG; Piek JJ; de Winter RJ
Catheter Cardiovasc Interv; 2011 Aug; 78(2):189-95. PubMed ID: 21542109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
